End of Week One

Yesterday marked the conclusion of the first full week of trials over the Dover, PA School Board?s decision to include intelligent design in the science curriculum. This week was devoted to the plaintiffs? witnesses. Lawyers questioned Drs. Kenneth Miller, a Brown University cell and molecular biologist, Robert Pennock, professor of science and philosophy at Michigan State, and Jack Haught, professor of theology at Georgetown University. The professors ? presumably picked from hundreds of scien

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Yesterday marked the conclusion of the first full week of trials over the Dover, PA School Board?s decision to include intelligent design in the science curriculum. This week was devoted to the plaintiffs? witnesses. Lawyers questioned Drs. Kenneth Miller, a Brown University cell and molecular biologist, Robert Pennock, professor of science and philosophy at Michigan State, and Jack Haught, professor of theology at Georgetown University. The professors ? presumably picked from hundreds of scientists who could reasonably explain the tenets of scientific investigation, the nature of fact and theory, and reasons that intelligent design doesn?t fit any of these frameworks ? appear to have performed admirably. Here we had an honest-to ? well ? we had a real science-on-trial type case. Although a cute highlight, brilliantly teased out by columnist Mike Argento, appeared to have dipped a fair stretch down the rabbit hole. Any reasonable person should notice the straw ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies